News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Match Group bakes Tinder recovery and Hinge growth into guidance, supporting further upside for MTCH despite the recent rally.
  • PTC appears undervalued with strong free cash flow and mid-teens multiple re-rating potential from AI and digital twin expansion.
  • Teladoc offers cheap cash-flow metrics and an outcomes-based integrated care product that could drive higher-margin revenue.
  • Marvell is positioned as a leveraged AI infrastructure play via data-center exposure and Nvidia ties, supporting a long-trade thesis.
  • Viavi's revenue and profit acceleration with bullish guidance sets up a mid-term swing trade tied to optical networking demand.

Latest Articles

Brookfield Asset Management Announces Record Second Quarter Results

Brookfield Asset Management Announces Record Second Quarter Results

Brookfield Asset Management reported record second quarter fundraising of $77 billion and a 20% year-over-year increase in fee-related earnings to $808 million. The company highlighted strong capital deployment across infrastructure, energy, private equity, real estate, and credit sectors, along with strategic partnerships in AI infrastructure and …

Gibraltar Industries Surges After Strong Q2 Results and Upbeat Guidance

Gibraltar Industries Surges After Strong Q2 Results and Upbeat Guidance

Gibraltar Industries rallied in early trading after reporting Q2 2026 results that significantly exceeded expectations. Revenue rose 64.6% year over year to $509.5 million, driven largely by the February 2026 OmniMax acquisition and organic growth. Non-GAAP EPS of $1.11 topped analyst forecasts by roughly 9%, while adjusted EBITDA and full-year gui…

Buy Zscaler on Real Clear Evidence: Patience Required After the May Shock

Buy Zscaler on Real Clear Evidence: Patience Required After the May Shock

Zscaler (ZS) remains a market-leading zero-trust security platform with strong free cash flow and a clear path to expand ARR via cloud and AI security products. But execution concerns and a brutal guidance reaction have left the stock volatile. This trade idea buys a measured pullback and gives the company time to prove sales stabilization and AI r…

Galaxy Digital Shares Drop After Q2 Loss and Security Fallout

Galaxy Digital Shares Drop After Q2 Loss and Security Fallout

Galaxy Digital shares fell sharply in pre-market trading after the company reported a Q2 2026 net loss driven by significant digital asset impairments, missed adjusted EPS, and a high-profile industry security incident tied to a Coldcard wallet vulnerability. The quarter included the first data center revenue from a 133-megawatt delivery to CoreWea…

HSBC ADR Falls After Earnings Rally Is Met with Profit-Taking

HSBC ADR Falls After Earnings Rally Is Met with Profit-Taking

HSBC Holdings PLC ADR slipped in pre-market trading after its robust first-half 2026 results were largely priced in, leaving the stock vulnerable to profit-taking. Despite beats on earnings and revenue, a near-52-week high, continued restructuring charges tied to Australian retail exits, and the resumption of a share buyback combined to push the AD…

AstraZeneca Pops After Source Denies Merger Talks with Bristol Myers Squibb

AstraZeneca Pops After Source Denies Merger Talks with Bristol Myers Squibb

AstraZeneca shares jumped roughly 6% after a senior source told Reuters there are 'no discussions' between AstraZeneca and Bristol Myers Squibb about a merger. The denial partially reversed a nearly 9% drop AZN suffered earlier in the week amid deal rumours. Market participants are reassessing both stocks as U.S. trading will provide another window…

Vivos Therapeutics Announces Issuance of New US Patent Broadening Protection for Its Vivos CARE Oral Medical Device Technology

Vivos Therapeutics Announces Issuance of New US Patent Broadening Protection for Its Vivos CARE Oral Medical Device Technology

Vivos Therapeutics announced the issuance of a new US patent (No. 12,697,190) that broadens protection for its Vivos CARE oral medical devices, designed to treat obstructive sleep apnea (OSA). This continuation patent complements their earlier patent, enhancing protection against competitors. With FDA 510(k) clearances for treating severe OSA in ad…

Splash Beverage Group Partners with Veteran Cannabinoid Drug-Development Team to Advance CannEpil® Through FDA Veterinary Pathway

Splash Beverage Group Partners with Veteran Cannabinoid Drug-Development Team to Advance CannEpil® Through FDA Veterinary Pathway

Splash Beverage Group has entered a strategic collaboration with Lupvindol Biosciences Ltd. to advance CannEpil® as a potential FDA-regulated veterinary pharmaceutical product focused initially on companion-animal oncology and chronic pain management. The program aims to navigate the FDA veterinary drug approval pathway to achieve conditional appro…

Acrivon Advances ACR-2316, a Potential First-in-Class WEE1/PKMYT1 Inhibitor, into Randomized Dose Expansion in its Ongoing Phase 1/2 Study

Acrivon Advances ACR-2316, a Potential First-in-Class WEE1/PKMYT1 Inhibitor, into Randomized Dose Expansion in its Ongoing Phase 1/2 Study

Acrivon Therapeutics announced that its investigational drug ACR-2316, a novel WEE1/PKMYT1 inhibitor, has progressed into the randomized dose expansion phase of its ongoing Phase 1/2 clinical trial. The advancement follows a favorable safety profile and evidence of durable clinical activity, including tumor shrinkage and partial responses in heavil…

Charlton Aria Acquisition Corporation Announces Extension of the Deadline for an Initial Business Combination

Charlton Aria Acquisition Corporation Announces Extension of the Deadline for an Initial Business Combination

Charlton Aria Acquisition Corporation, a Cayman Islands exempted blank check company listed on Nasdaq, announced a three-month extension until October 25, 2026, for completing its initial business combination. This marks the second extension after the Sponsor deposited $850,000 into the trust account, allowing more time to identify and consummate a…

FingerMotion Announces Leadership Change

FingerMotion Announces Leadership Change

FingerMotion, Inc., a Nasdaq-listed mobile services and technology company, announced a leadership change with the appointment of Jolie Kahn as CEO, succeeding Martin Shen. Kahn brings extensive experience in corporate finance, public company management, and digital asset-related businesses. The company aims to leverage its growing user base and in…